Rayos, a new delayed-release prednisone designed for evening dosing

December 2012

You'll see ads for Rayos, a new delayed-release prednisone designed for evening dosing.

It'll be promoted for rheumatoid arthritis first...then later for COPD, asthma, and other conditions that require an oral steroid.

Rayos tablets are coated to delay drug release for about 4 hours after a dose. Then absorption is similar to immediate-release prednisone.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Cardiology whether ALL patients with coronary artery disease should take a beta-blocker
Anticoagulants Xarelto (rivaroxaban) will be used to TREAT venous thromboembolism
Anticoagulants more about bleeding with Pradaxa (dabigatran)
Gastroenterology Linzess (lin-ZESS, linaclotide) for irritable bowel syndrome with constipation or chronic constipation in adults
Corticosteroids Rayos, a new delayed-release prednisone designed for evening dosing
Vaccines Prevnar 13 vaccine will be used in certain ADULTS
Vaccines New CDC guidelines will bring more focus on proper vaccine storage
Diabetes debate about whether diabetes patients who don't use insulin benefit from monitoring their blood glucose
Respiratory & Allergy Tudorza Pressair (TU-door-za, aclidinium), a new inhaled bronchodilator for COPD
Gout rev up promotion of Uloric (febuxostat) for managing gout
Compounding new oversight of pharmacy compounding
Interactions PPIs with methotrexate can lead to methotrexate toxicity
Practice enjoy the holiday letter from our staff